Denali Therapeutics Inc (DNLI)
29.43
+0.16
(+0.55%)
USD |
NASDAQ |
Sep 27, 16:00
29.43
0.00 (0.00%)
After-Hours: 20:00
Denali Therapeutics Revenue (Annual): 330.53M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 330.53M |
December 31, 2022 | 108.46M |
December 31, 2021 | 48.66M |
Date | Value |
---|---|
December 31, 2020 | 335.66M |
December 31, 2019 | 26.68M |
December 31, 2018 | 129.16M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
26.68M
Minimum
2019
335.66M
Maximum
2020
170.00M
Average
108.46M
Median
2022
Revenue (Annual) Benchmarks
AIM ImmunoTech Inc | 0.202M |
Perspective Therapeutics Inc | -- |
Protalix BioTherapeutics Inc | 65.49M |
Electromed Inc | 54.72M |
Armata Pharmaceuticals Inc | -- |